| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |